CrossRoads Extremity Systems, LLC

Based in the US, CrossRoads Extremity Systems specializes in developing advanced orthopedic solutions, focusing on innovative foot implant systems that enhance surgical outcomes and improve patient recovery. CrossRoads Extremity Systems provides orthopedic solutions with a focus on foot implant systems. Founded in 2014 in Memphis, US, the company was co-founded by Chad Hollis and Vernon Hartdegen, who has a background in the medical device industry. The company has engaged in 3 financial deals to date and operates independently without subsidiaries or parent companies.

CrossRoads Extremity Systems specializes in advanced orthopedic solutions, primarily focusing on foot implant systems such as the DynaForce® Staple Compression Plates (SCP) and the MINIBunion® system. The DynaForce® SCP is engineered to facilitate rapid healing of bone fusions by utilizing a staple compression mechanism that enhances stability and promotes faster recovery times. The MINIBunion® offers a minimally invasive approach to bunion correction, aiming to reduce patient recovery periods while maintaining effective correction outcomes. Their innovative products are designed for use in various surgical procedures, catering to orthopedic surgeons and healthcare facilities across the United States and internationally.

The company serves a diverse clientele that includes hospitals, surgical centers, and orthopedic specialists, focusing on improving surgical procedures and patient outcomes in the realm of extremity care. CrossRoads Extremity Systems generates revenue through direct sales of its proprietary medical devices to healthcare providers and institutions. Clients place orders based on their surgical needs, leading to regular transactions structured around product demand. The company's flagship products, including the DynaForce® SCP and the MINIBunion®, are sold through a combination of direct distribution and partnerships with orthopedic supply distributors, allowing for broader market reach.

Pricing structures are established based on the complexity and technological advancements of the products, ensuring accessibility for healthcare providers while supporting the company’s operational goals. The revenue model emphasizes a business-to-business approach, where transactions are facilitated through established relationships with healthcare professionals and organizations that prioritize innovative orthopedic solutions. CrossRoads Extremity Systems is focused on expanding its product line and geographic reach. The company is working on the design and launch of new orthopedic solutions, although specific release dates have not been disclosed.

Additionally, they plan to target international markets for expansion, enhancing their global presence in the orthopedic sector. Recent funding was secured through acquisition by MB Venture Partners, which will support these strategic initiatives.